Alivus Life Sciences Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Alivus Life Sciences Ltd. on BSE

Search Inside the pdf :

Alivus Life Sciences Ltd.

08 May 2025

1100.10

-1.39%

Company Update

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Enclosed please find herewith the details of Earnings Call slated for Friday, May 16, 2025 at 8:30 a.m. - 9:30 a.m. (IST), for your information and record.

pdf

Alivus Life Sciences Ltd.

08 May 2025

1100.10

-1.39%

SAST

Alivus Life Sciences Ltd - 543322 - Closure of Trading Window

BSE India

As per the ''Code of Conduct for Prevention of Insider Trading" and pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has intimated its ''designated persons'' regarding closure of Trading Window from March 31, 2025 to May 17, 2025 (both days inclusive) for the purpose of approval of Audited Financial Results for quarter and year ended March 31, 2025

pdf

Alivus Life Sciences Ltd.

08 May 2025

1100.10

-1.39%

Board Meeting

Alivus Life Sciences Ltd - 543322 - Board Meeting Intimation for To Consider And Approve The …

BSE India

Alivus Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March, 2025 and to consider and recommend dividend, if any, on Equity shares for the year ended March 31, 2025.

pdf

Alivus Life Sciences Ltd.

08 May 2025

1100.10

-1.39%

Company Update

Alivus Life Sciences Ltd - 543322 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Plwase find attached herewith Annual Secretarial Compliance Report for the year ended 31st March, 2025.

pdf

Alivus Life Sciences Ltd.

30 Apr 2025

1100.10

-1.39%

Company Update

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

Allotment of Equity Shares under the "Employee Stock Options Scheme 2021"

pdf

Alivus Life Sciences Ltd.

17 Apr 2025

1100.10

-1.39%

Corp. Note

Alivus Life Sciences Ltd - 543322 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAlivus Life Sciences Ltd 2CIN NO.L74900PN2011PLC139963 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)INDIA RATINGS AND RESEARCH PVT. LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rudalf Corriea Designation: Compliance officer and Company Secretary EmailId: complianceofficer@alivus.com Name of the Chief Financial Officer: Tushar Mistry Designation: Chief Financial Officer EmailId: complianceofficer@alivus.com Date: 17/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Alivus Life Sciences Ltd.

03 Apr 2025

1100.10

-1.39%

Company Update

Alivus Life Sciences Ltd - 543322 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations …

BSE India

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

pdf

Alivus Life Sciences Ltd.

02 Apr 2025

1100.10

-1.39%

Company Update

Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Acquisition

BSE India

Intimation of Share Purchase cum Subscription Shareholders'' Agreement and Power Supply Agreement between Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) and Torrent Urja 19 Private Limited.

pdf